Overview

Neutrino Regimen for Treatment-experienced HCV GT1 Patients

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of NEUTRINO regimen in Chinese chronic HCV genotype 1b treatment-experienced patients.
Phase:
Phase 4
Details
Lead Sponsor:
Humanity & Healthy GI and Liver Centre
Humanity and Health Research Centre
Collaborator:
Beijing 302 Hospital
Treatments:
Sofosbuvir